Increasing the power of cancer radiotherapy.

An innovative solution to eliminate hypoxia, the most fundamental issue in cancer.

NEWS

Update from our latest activity

  • R&D
KORTUC’s clinical research result of unresectable recurrent uterine cervical cancer will be presented at ABS Annual Conference in Denver
  • R&D
Updated References
  • R&D
KORTUC’s therapy and its related basic research is to be presented by Dr. Navita Somaiah, Chief Principal Investigator of the ongoing pivotal KORTUC P2, at ARR 2022
VIEW MORE NEWS

OVERVIEW

Our company mission toward society

OUR PURPOSE

To provide more option for cancer radiotherapy.

WHAT WE OFFER

An innovative radiosensitizer that maximizes safely the effectiveness of radiotherapy.

HOW DO WE MAKE IT HAPPEN?

Our radiosensitizer consisting mainly of H2O2, injected into tumor, eliminates hypoxia and makes tumor radiosensitive.

EXPLORE KORTUC

More about our company and the story behind our product

OUR ACTIVITY

How it works and why its innovative.

OUR HISTORY

How it all started and the story behind the research & development.

OUR PIPELINE

Our future plan for R&D and product release.

OUR COMPANY

An innovative solution to eliminate the most fundamental issue